|
|
The 3rd World Congress on
Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)
Hilton Hotel, Prague, Czech Republic, May 13-16, 2010 |
|
| |
| Sunday, May 16, 2010 |
 |
|
|
HALL A |
|
08:30-10:00
08:30-08:35 |
Session 25
HYPERTENSION IN DIABETES
Chairperson: A. Natali, Italy |
|
08:35-09:05
09:05-09:25
09:25-10:00 |
Vascular disease endothelial function and clinical implication and endothelium. target for therapy
A. Natali, Italy
Microvascular dysfunction as a central factor linking obesity to diabetes and hypertension
C.D.A. Stehouwer, Netherlands
PANEL DISCUSSION
A. Natali, Italy C.D.A Stehouwer, Netherlands |
|
HALL B |
|
08:30-10:00
08:30-08:35 |
CARDIOVASCULAR RISK FACTORS
Chairpersons: D. Micic, Serbia E. Standl, Germany |
| 08:35-09:00
09:00-09:40
09:00-09:20
09:20-09:40
09:40-10:00
|
Should C-reactive protein (CRP) be a target of therapy?
L.A. Leiter, Canada
A1C to diagnose T2D
Pro: E. Bonora, Italy
Con: J. Tuomilehto, Finland
PANEL DISCUSSION
E. Bonora, Italy L.A. Leiter, Canada J. Tuomilehto, Finland
|
|
|
|
|
10:30-10:40 |
BEST ABSTRACTS AWARD |
|
|
|
10:40-11:45
10:40-10:45 |
Session 27
FUTURE THERAPY OF T2D
Chairperson: I. Raz, Israel |
|
10:45-11:05
11:05-11:25
11:25-11:45
|
Glucokinase Activator (GK): F. Matschinsky, USA
Sodium-glucose transport proteins-2 (SGLT2): E. Boutati, Greece
Long acting GLP1: A.J. Garber, USA |
|
|
|
|
WebStudio.co.il